Exact Mass: 385.1249

Exact Mass Matches: 385.1249

Found 97 metabolites which its exact mass value is equals to given mass value 385.1249, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Nocardicin G

Nocardicin G

C19H19N3O6 (385.1274)


A monobactam obtained by formal condensation of the carboxy group of (2R)-amino(4-hydroxyphenyl)acetic acid with the amino group of (2R)-[(3S)-3-amino-2-oxoazetidin-1-yl](4-hydroxyphenyl)acetic acid

   

Tepoxalin

3-[5-(4-chlorophenyl)-1-(4-methoxyphenyl)-1H-pyrazol-3-yl]-N-hydroxy-N-methylpropanamide

C20H20ClN3O3 (385.1193)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents Tepoxalin is a dual inhibitor of COX and 5-lipoxygenase (5-LO) with potent anti-inflammatory activity and a favorable gastrointestinal profile[1].

   

Sarafloxacin

6-fluoro-1-(4-Fluorophenyl)-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid, 9ci

C20H17F2N3O3 (385.1238)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic Sarafloxacin is used for control of Campylobacter infections in poultr It is used for control of Campylobacter infections in poultry

   

Niazicin

(2S,3R,4S,5R,6S)-4,5-Dihydroxy-6-[4-({[methoxy(sulphanyl)methylidene]amino}methyl)phenoxy]-2-methyloxan-3-yl acetic acid

C17H23NO7S (385.1195)


Niazicin is a glucosinolate and a naturally occurring thiocarbamate. It has been isolated from the leaves of Moringa oleifera (horseradish tree). It is found in fats and oils, herbs and spices, and green vegetables. The trans and cis rotamers of niazicin (niazicin A and niazicin B, respectively) differ in the orientation of the NH group with respect to sulfur. Constituent of Moringa oleifera (horseradish tree). Niazicin A is found in fats and oils, herbs and spices, and green vegetables.

   

Nilvadipine

3-methyl 5-propan-2-yl 2-cyano-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate

C19H19N3O6 (385.1274)


Nilvadipine is only found in individuals that have used or taken this drug. It is a calcium channel blocker (CCB) for treatment of hypertension.Nilvadipine inhibits the influx of extracellular calcium through myocardial and vascular membrane pores by physically plugging the channel. The decrease in intracellular calcium inhibits the contractile processes of smooth muscle cells, causing dilation of the coronary and systemic arteries, increased oxygen delivery to the myocardial tissue, decreased total peripheral resistance, decreased systemic blood pressure, and decreased afterload. C - Cardiovascular system > C08 - Calcium channel blockers > C08C - Selective calcium channel blockers with mainly vascular effects > C08CA - Dihydropyridine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker

   

2,5-Dioxopyrrolidin-1-YL 4-(pyren-1-YL)butanoate

2,5-Dioxopyrrolidin-1-yl 4-(pyren-1-yl)butanoic acid

C24H19NO4 (385.1314)


   

(4As,5aS,6S,12aS)-1,6,10,11-tetrahydroxy-6-methyl-3,12-dioxo-4a,5,5a,12a-tetrahydro-4H-tetracene-2-carboxamide

(4As,5aS,6S,12aS)-1,6,10,11-tetrahydroxy-6-methyl-3,12-dioxo-4a,5,5a,12a-tetrahydro-4H-tetracene-2-carboxamide

C20H19NO7 (385.1161)


   

(4As,5aR,6R,12aR)-1,10,11,12a-tetrahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide

(4As,5aR,6R,12aR)-1,10,11,12a-tetrahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide

C20H19NO7 (385.1161)


   

Ecadotril

benzyl 2-{2-[(acetylsulfanyl)methyl]-3-phenylpropanamido}acetate

C21H23NO4S (385.1348)


   

Fleroxacin N-oxide

4-[3-carboxy-6,8-difluoro-1-(2-fluoroethyl)-4-oxo-1,4-dihydroquinolin-7-yl]-1-methylpiperazin-1-ium-1-olate

C17H18F3N3O4 (385.1249)


   

Racecadotril

Racecadotril (Acetorphan)

C21H23NO4S (385.1348)


A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents C78276 - Agent Affecting Digestive System or Metabolism > C266 - Antidiarrheal Agent D005765 - Gastrointestinal Agents > D000930 - Antidiarrheals D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors C471 - Enzyme Inhibitor > C783 - Protease Inhibitor

   

Anthocyanin 3-O-beta-D-glucoside

Anthocyanin 3-O-beta-D-glucoside

C21H21O7+ (385.1287)


   
   
   

NEOLAMELLARIN A

NEOLAMELLARIN A

C24H19NO4 (385.1314)


   

5-[(R)-Hydroxy-((S)-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isochinolin-5-yl)-methyl]-benzo[1,3]dioxol-4-carbonsaeure|5-[(R)-hydroxy-((S)-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-methyl]-benzo[1,3]dioxole-4-carboxylic acid

5-[(R)-Hydroxy-((S)-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isochinolin-5-yl)-methyl]-benzo[1,3]dioxol-4-carbonsaeure|5-[(R)-hydroxy-((S)-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-methyl]-benzo[1,3]dioxole-4-carboxylic acid

C20H19NO7 (385.1161)


   
   

Ianthellidone C

Ianthellidone C

C20H19NO7 (385.1161)


   

Tunichrome Mm-1|Tunichrome Mm1

Tunichrome Mm-1|Tunichrome Mm1

C19H19N3O6 (385.1274)


   
   
   
   
   
   

Sarafloxacin

Sarafloxacin

C20H17F2N3O3 (385.1238)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic CONFIDENCE standard compound; EAWAG_UCHEM_ID 3620 EAWAG_UCHEM_ID 3620; CONFIDENCE standard compound CONFIDENCE standard compound; INTERNAL_ID 1035

   

Nilvadipine (ARC029)

Nilvadipine (ARC029)

C19H19N3O6 (385.1274)


   
   
   
   
   
   
   
   

Lys-Met-OH

(S)-2-(3-(4-aminobutoxy)-4-nitrobenzamido)-5-(methylthio)pentanoic acid

C16H23N3O6S (385.1307)


   

Met-Lys-OH

(S)-7-amino-2-(3-(2-(methylthio)ethoxy)-4-nitrobenzamido)heptanoic acid

C16H23N3O6S (385.1307)


   

Nilvadipine

3-methyl 5-propan-2-yl 2-cyano-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate

C19H19N3O6 (385.1274)


C - Cardiovascular system > C08 - Calcium channel blockers > C08C - Selective calcium channel blockers with mainly vascular effects > C08CA - Dihydropyridine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker

   

2,6-dimethyl-4-(3-nitrophenyl)-5-methoxycarbonyl-1,4-dihydropyridine-3-carboxylic acid 2-cyanoethyl ester

2,6-dimethyl-4-(3-nitrophenyl)-5-methoxycarbonyl-1,4-dihydropyridine-3-carboxylic acid 2-cyanoethyl ester

C19H19N3O6 (385.1274)


   
   

Ecadotril

Ecadotril

C21H23NO4S (385.1348)


D005765 - Gastrointestinal Agents > D000930 - Antidiarrheals D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors C471 - Enzyme Inhibitor > C783 - Protease Inhibitor

   

Fmoc-L-β-homomethionine

Fmoc-L-β-homomethionine

C21H23NO4S (385.1348)


   
   

(2S,4R)-1-(tert-butoxycarbonyl)-4-(tosyloxy)pyrrolidine-2-carboxylic acid

(2S,4R)-1-(tert-butoxycarbonyl)-4-(tosyloxy)pyrrolidine-2-carboxylic acid

C17H23NO7S (385.1195)


   

2-(6,7-DIMETHOXY-3,3-DIMETHYL-3,4-DIHYDRO-ISOQUINOLIN-1-YLMETHYLSULFANYL)-BENZOIC ACID

2-(6,7-DIMETHOXY-3,3-DIMETHYL-3,4-DIHYDRO-ISOQUINOLIN-1-YLMETHYLSULFANYL)-BENZOIC ACID

C21H23NO4S (385.1348)


   

Fmoc n-me-l-met-oh

Fmoc n-me-l-met-oh

C21H23NO4S (385.1348)


   

L-ASPARTIC ACID BIS-ALLYL ESTER P-TOLUENESULFONATE SALT

L-ASPARTIC ACID BIS-ALLYL ESTER P-TOLUENESULFONATE SALT

C17H23NO7S (385.1195)


   

(R,S)-FMOC-1,3-DIHYDRO-2H-ISOINDOLE CARBOXYLIC ACID

(R,S)-FMOC-1,3-DIHYDRO-2H-ISOINDOLE CARBOXYLIC ACID

C24H19NO4 (385.1314)


   

N,N-BIS(DIPHENYLPHOSPHINO)AMINE

N,N-BIS(DIPHENYLPHOSPHINO)AMINE

C24H21NP2 (385.1149)


   

Denibulin

methyl N-[6-[4-[[(2S)-2-aminopropanoyl]amino]phenyl]sulfanyl-1H-benzimidazol-2-yl]carbamate

C18H19N5O3S (385.1209)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent

   

2-[ethyl[3-methyl-4-[(5-nitro-2,1-benzisothiazol-3-yl)azo]phenyl]amino]ethanol

2-[ethyl[3-methyl-4-[(5-nitro-2,1-benzisothiazol-3-yl)azo]phenyl]amino]ethanol

C18H19N5O3S (385.1209)


   

N-Hydroxysuccinimidyl Pyrenebutanoate

2,5-Dioxopyrrolidin-1-YL 4-(pyren-1-YL)butanoate

C24H19NO4 (385.1314)


   

Capecitabine-2,3-cyclic Carbonate

Capecitabine-2,3-cyclic Carbonate

C16H20FN3O7 (385.1285)


   

2-METHOXY-5-(6-METHOXY-7-(2-METHOXYETHOXY)QUINAZOLIN-4-YLAMINO)CYCLOHEXA-2,5-DIENE-1,4-DIONE

2-METHOXY-5-(6-METHOXY-7-(2-METHOXYETHOXY)QUINAZOLIN-4-YLAMINO)CYCLOHEXA-2,5-DIENE-1,4-DIONE

C19H19N3O6 (385.1274)


   

FMOC-L-INDOLINE-2-CARBOXYLIC ACID

FMOC-L-INDOLINE-2-CARBOXYLIC ACID

C24H19NO4 (385.1314)


   

CEPHRADINE (200 MG)

CEPHRADINE (200 MG)

C16H23N3O6S (385.1307)


   

(-)-O,O-DIBENZOYL-L-TARTARIC ACID MONO(DIMETHYLAMIDE)

(-)-O,O-DIBENZOYL-L-TARTARIC ACID MONO(DIMETHYLAMIDE)

C20H19NO7 (385.1161)


   

Ciprofloxacin Hydrochloride

Ciprofloxacin Hydrochloride hydrate

C17H21ClFN3O4 (385.1205)


D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065609 - Cytochrome P-450 CYP1A2 Inhibitors D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C52588 - Antibacterial Agent > C280 - Antitubercular Agent C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic Ciprofloxacin (Bay-09867) hydrochloride monohydrate is a potent, orally active topoisomerase IV inhibitor. Ciprofloxacin hydrochloride monohydrate induces mitochondrial DNA and nuclear DNA damage and lead to mitochondrial dysfunction, ROS production. Ciprofloxacin hydrochloride monohydrate has anti-proliferative activity and induces apoptosis. Ciprofloxacin hydrochloride monohydrate is a fluoroquinolone antibiotic, exhibiting potent antibacterial activity[1][2][3][4].

   

6,8-Difluoro-1-(2-fluoroethyl)-7-(4-methyl-4-oxidopiperazin-4-ium-1-yl)-4-oxoquinoline-3-carboxylic acid

6,8-Difluoro-1-(2-fluoroethyl)-7-(4-methyl-4-oxidopiperazin-4-ium-1-yl)-4-oxoquinoline-3-carboxylic acid

C17H18F3N3O4 (385.1249)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones

   

Momfluorothrin, (Z,1R,3R)-

Momfluorothrin, (Z,1R,3R)-

C19H19F4NO3 (385.1301)


   

2-phenyl-N-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)-4-quinolinecarboxamide

2-phenyl-N-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)-4-quinolinecarboxamide

C23H19N3OS (385.1249)


   

3(S)-Methylcarbamoyl-7-sulfoamino-3,4-dihydro-1H-isoquinoline-2-carboxylic acid tert-butyl ester

3(S)-Methylcarbamoyl-7-sulfoamino-3,4-dihydro-1H-isoquinoline-2-carboxylic acid tert-butyl ester

C16H23N3O6S (385.1307)


   

3(R)-Methylcarbamoyl-7-sulfoamino-3,4-dihydro-1H-isoquinoline-2-carboxylic acid tert-butyl ester

3(R)-Methylcarbamoyl-7-sulfoamino-3,4-dihydro-1H-isoquinoline-2-carboxylic acid tert-butyl ester

C16H23N3O6S (385.1307)


   

[4,5-Dihydroxy-6-[4-[(methoxycarbothioylamino)methyl]phenoxy]-2-methyloxan-3-yl] acetate

[4,5-Dihydroxy-6-[4-[(methoxycarbothioylamino)methyl]phenoxy]-2-methyloxan-3-yl] acetate

C17H23NO7S (385.1195)


   

N-[3-(1,3-benzothiazol-2-yl)-7-propan-2-yl-4,5,6,8-tetrahydrothieno[2,3-c]azepin-2-yl]acetamide

N-[3-(1,3-benzothiazol-2-yl)-7-propan-2-yl-4,5,6,8-tetrahydrothieno[2,3-c]azepin-2-yl]acetamide

C20H23N3OS2 (385.1282)


   

N-[3-(1,3-benzothiazol-2-yl)-6-propan-2-yl-4,5,7,8-tetrahydrothieno[2,3-d]azepin-2-yl]acetamide

N-[3-(1,3-benzothiazol-2-yl)-6-propan-2-yl-4,5,7,8-tetrahydrothieno[2,3-d]azepin-2-yl]acetamide

C20H23N3OS2 (385.1282)


   

4-[[3-[[(4-Nitrophenyl)-oxomethyl]amino]-1-oxopropyl]amino]benzoic acid ethyl ester

4-[[3-[[(4-Nitrophenyl)-oxomethyl]amino]-1-oxopropyl]amino]benzoic acid ethyl ester

C19H19N3O6 (385.1274)


   

N-(4-chlorophenyl)-N-ethyl-6-(propan-2-ylamino)-4-(trifluoromethyl)-3-pyridinecarboxamide

N-(4-chlorophenyl)-N-ethyl-6-(propan-2-ylamino)-4-(trifluoromethyl)-3-pyridinecarboxamide

C18H19ClF3N3O (385.1169)


   

4-methyl-2-[3-methyl-4-(3-methylphenyl)azo-5-oxo-4H-pyrazol-1-yl]-5-thiazolecarboxylic acid ethyl ester

4-methyl-2-[3-methyl-4-(3-methylphenyl)azo-5-oxo-4H-pyrazol-1-yl]-5-thiazolecarboxylic acid ethyl ester

C18H19N5O3S (385.1209)


   
   
   
   

(3R,6R,14aR,14bR)-3-[(1R)-1-chloroethyl]-3,6-dihydroxy-6-methyl-5-methylidene-3,4,5,6,9,11,13,14,14a,14b-decahydro[1,6]dioxacyclododecino[2,3,4-gh]pyrrolizine-2,7-dione

(3R,6R,14aR,14bR)-3-[(1R)-1-chloroethyl]-3,6-dihydroxy-6-methyl-5-methylidene-3,4,5,6,9,11,13,14,14a,14b-decahydro[1,6]dioxacyclododecino[2,3,4-gh]pyrrolizine-2,7-dione

C18H24ClNO6 (385.1292)


   
   
   
   
   
   
   

3-(beta-D-Glucopyranosyloxy)-2-phenyl-1-benzopyrylium

3-(beta-D-Glucopyranosyloxy)-2-phenyl-1-benzopyrylium

C21H21O7+ (385.1287)


   

TEPOXALIN

TEPOXALIN

C20H20ClN3O3 (385.1193)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents Tepoxalin is a dual inhibitor of COX and 5-lipoxygenase (5-LO) with potent anti-inflammatory activity and a favorable gastrointestinal profile[1].

   

nocardicin G zwitterion

nocardicin G zwitterion

C19H19N3O6 (385.1274)


An amino acid zwitterion resulting from a transfer of a proton from the carboxy group to the amino group of nocardicin G; major species at pH 7.3.

   
   

dehydrojaconine

dehydrojaconine

C18H24ClNO6 (385.1292)


A pyrrolizine alkaloid that is jacoline in which the secondary hydroxy group has been replaced by a chlorine and the 5-methyl group has been replaced by methylene.

   

Anthocyanin 3'-O-beta-D-glucoside

Anthocyanin 3'-O-beta-D-glucoside

C21H21O7 (385.1287)


   

5-[(r)-hydroxy[(5s)-6-methyl-2h,5h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]methyl]-2h-1,3-benzodioxole-4-carboxylic acid

5-[(r)-hydroxy[(5s)-6-methyl-2h,5h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]methyl]-2h-1,3-benzodioxole-4-carboxylic acid

C20H19NO7 (385.1161)


   

3,4-bis(4-hydroxyphenyl)-1-(2-phenylethyl)pyrrole-2,5-dione

3,4-bis(4-hydroxyphenyl)-1-(2-phenylethyl)pyrrole-2,5-dione

C24H19NO4 (385.1314)


   

1,12,15-trihydroxy-16-methoxy-21-methyl-6,8-dioxa-21-azapentacyclo[10.9.0.0²,¹⁰.0⁵,⁹.0¹³,¹⁸]henicosa-2(10),3,5(9),13(18),14,16-hexaen-11-one

1,12,15-trihydroxy-16-methoxy-21-methyl-6,8-dioxa-21-azapentacyclo[10.9.0.0²,¹⁰.0⁵,⁹.0¹³,¹⁸]henicosa-2(10),3,5(9),13(18),14,16-hexaen-11-one

C20H19NO7 (385.1161)


   

3,4-dimethoxy-2-({5-oxo-2h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-6-yl}methyl)benzoic acid

3,4-dimethoxy-2-({5-oxo-2h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-6-yl}methyl)benzoic acid

C20H19NO7 (385.1161)


   

(1s,12s)-1,12,15-trihydroxy-16-methoxy-21-methyl-6,8-dioxa-21-azapentacyclo[10.9.0.0²,¹⁰.0⁵,⁹.0¹³,¹⁸]henicosa-2(10),3,5(9),13(18),14,16-hexaen-11-one

(1s,12s)-1,12,15-trihydroxy-16-methoxy-21-methyl-6,8-dioxa-21-azapentacyclo[10.9.0.0²,¹⁰.0⁵,⁹.0¹³,¹⁸]henicosa-2(10),3,5(9),13(18),14,16-hexaen-11-one

C20H19NO7 (385.1161)


   

(2r,3s,4r,5r,6r)-4,5-dihydroxy-6-[4-({[methoxy(sulfanyl)methylidene]amino}methyl)phenoxy]-2-methyloxan-3-yl acetate

(2r,3s,4r,5r,6r)-4,5-dihydroxy-6-[4-({[methoxy(sulfanyl)methylidene]amino}methyl)phenoxy]-2-methyloxan-3-yl acetate

C17H23NO7S (385.1195)


   

4,5-dihydroxy-6-[4-({[methoxy(sulfanyl)methylidene]amino}methyl)phenoxy]-2-methyloxan-3-yl acetate

4,5-dihydroxy-6-[4-({[methoxy(sulfanyl)methylidene]amino}methyl)phenoxy]-2-methyloxan-3-yl acetate

C17H23NO7S (385.1195)


   

(3r)-4-(1,4-dihydroxy-5-methoxy-9,10-dioxoanthracen-2-yl)-3-hydroxy-3-methylbutanimidic acid

(3r)-4-(1,4-dihydroxy-5-methoxy-9,10-dioxoanthracen-2-yl)-3-hydroxy-3-methylbutanimidic acid

C20H19NO7 (385.1161)


   

methyl (2r)-2,3-dihydroxy-2-[(2r)-5-hydroxy-11-methyl-6-oxo-1h,2h-furo[2,3-c]acridin-2-yl]propanoate

methyl (2r)-2,3-dihydroxy-2-[(2r)-5-hydroxy-11-methyl-6-oxo-1h,2h-furo[2,3-c]acridin-2-yl]propanoate

C20H19NO7 (385.1161)


   

methyl 2,3-dihydroxy-2-{5-hydroxy-11-methyl-6-oxo-1h,2h-furo[2,3-c]acridin-2-yl}propanoate

methyl 2,3-dihydroxy-2-{5-hydroxy-11-methyl-6-oxo-1h,2h-furo[2,3-c]acridin-2-yl}propanoate

C20H19NO7 (385.1161)


   

5-[hydroxy({6-methyl-2h,5h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-5-yl})methyl]-2h-1,3-benzodioxole-4-carboxylic acid

5-[hydroxy({6-methyl-2h,5h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-5-yl})methyl]-2h-1,3-benzodioxole-4-carboxylic acid

C20H19NO7 (385.1161)


   

(2s,3r,4s,5r,6s)-4,5-dihydroxy-6-[4-({[methoxy(sulfanyl)methylidene]amino}methyl)phenoxy]-2-methyloxan-3-yl acetate

(2s,3r,4s,5r,6s)-4,5-dihydroxy-6-[4-({[methoxy(sulfanyl)methylidene]amino}methyl)phenoxy]-2-methyloxan-3-yl acetate

C17H23NO7S (385.1195)


   

(1r,4r,7r,17r)-4-(1-chloroethyl)-4,7-dihydroxy-7-methyl-6-methylidene-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-ene-3,8-dione

(1r,4r,7r,17r)-4-(1-chloroethyl)-4,7-dihydroxy-7-methyl-6-methylidene-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-ene-3,8-dione

C18H24ClNO6 (385.1292)


   

6,11-dihydroxy-2,2-dimethyl-12-phenyl-5h-1-oxa-5-azatetraphen-10-one

6,11-dihydroxy-2,2-dimethyl-12-phenyl-5h-1-oxa-5-azatetraphen-10-one

C24H19NO4 (385.1314)